GenMark Dx is an industry leader in multiplex molecular diagnostics

Lenhoff, Alan
September 2012
MLO: Medical Laboratory Observer;Sep2012, Vol. 44 Issue 9, p60
Academic Journal
The article reports that GenMark provides high medical value and tests that are easy to perform. It markets three tests approved by FDA for In vitro diagnostics (IVD) use, including Gystic Fibrosis Genotyping Test, Warfarin Sensitivity Test, and Thrombophilia Risk Test. It offers eSensor XT-8 System which provides customers with accurate, standardized assays to improve the efficiency of the laboratory.


Related Articles

  • Biocare Medical CEO touts multiplex solution to solve complex cases. DiRamio, Denise // MLO: Medical Laboratory Observer;Jun2011, Vol. 43 Issue 6, p48 

    The article offers the views of Roy Paxton Yih, president of Biocare Medical, regarding his company, its multiplex solutions being offered and its community engagement efforts. Yih says that Biocare Medical offers innovative diagnostic products like the Multiplex Immunohistochemistry (IHC)...

  • Phthisis Diagnostics develops innovative molecular diagnostics products. Lenhoff, Alan // MLO: Medical Laboratory Observer;Nov2012, Vol. 44 Issue 11, p64 

    the article offers brief information on the "Phthisis Diagnostics," a research and development company, which develops the molecular diagnostics products such as 'E-Sphere Simple NA Kit.'

  • Seegene develops highly multiplexed diagnostic tests that enable cost-effective, responsive, and tailored patient care. Lenhoff, Alan // MLO: Medical Laboratory Observer;Jun2013, Vol. 45 Issue 6, p56 

    The article offers information about Seegene Institute of Life Sciences' real-time solution TOCE for the simultaneous detection and/or differentiation of up to 20 analytes, the MagicPlex Sepsis Test for identification of pathogens, and the MTB XDR for low-cost multidrug resistant testing.

  • Executive snapshot. Lenhoff, Alan // MLO: Medical Laboratory Observer;May2013, Vol. 45 Issue 5, p68 

    The article offers executive news brief as of May 2013. BioFire, diagnostics company has created innovative, highly integrated molecular system FilmArray which automatically do sample preparation, an incredibly high level of polymerase chain reaction (PCR) multiplexing, and high-resolution...

  • Affymetrix develops and manufactures products and systems for translational science and molecular diagnostics. Lenhoff, Alan // MLO: Medical Laboratory Observer;Jun2014, Vol. 46 Issue 6, p52 

    An interview with Affymetrix president Frank Whitney is presented. He talks about development of systems and products for translational science. When asked about their area of expertise, he says it is the manufacture of systems and products for cells, gene analysis and agrigenomics. Whitney says...

  • OpGen helps healthcare providers respond to the challenge of antibiotic-resistant infections. Lenhoff, Alan // MLO: Medical Laboratory Observer;Sep2014, Vol. 46 Issue 9, p40 

    An interview with OpGen, Inc. chairman and chief executive officer (CEO) Evan Jones is presented. He talks about the company's expertise, particularly in the fields of microbial genetics, molecular diagnostics, and bioinformatics. He also explains their genome research technology and...

  • bioMérieux, Biocartis to co-develop assays.  // Medical Device Daily;11/8/2010, Vol. 14 Issue 217, p7 

    The article reports on the strategic agreement of bioMérieux and Biocartis to co-develop assays based on Biocartis' molecular diagnostics system and to co-distribute the assays starting 2012. The agreement also awards bioMérieux worldwide exclusive rights to develop and commercialize...

  • PrimeraDx to co-develop diagnostics with Quest.  // Medical Device Daily;3/27/2013, Vol. 17 Issue 59, p2 

    This article reports on an agreement formed by molecular diagnostics company PrimeraDx and diagnostics information services company Quest Diagnostics.

  • HTG Changes Name to HTG Molecular Diagnostics.  // Biomedical Market Newsletter;4/30/2011, p469 

    The article reports on the move of HTG Inc. in Tucson, Arizona to change its name HTG Molecular Diagnostics to reflect its strategic vision and direction in offering molecular testing capabilities to its customers. The company's testing solutions include multiplexed and multi-parameter assays...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics